Randolph R K, Winkler K E, Ross A C
Department of Physiology and Biochemistry, Medical College of Pennsylvania, Philadelphia 19129.
Arch Biochem Biophys. 1991 Aug 1;288(2):500-8. doi: 10.1016/0003-9861(91)90227-a.
Retinol esterification was examined in microsomes from rat liver and lactating mammary gland as a function of the form of retinol substrate, dependence on fatty acyl CoA, and sensitivity to phenylmethylsulfonyl fluoride (PMSF). Retinol bound to cellular retinol-binding protein (CRBP) or dispersed in solvent was esterified in a fatty acyl CoA-independent, PMSF-sensitive reaction, consistent with lecithin:retinol acyltransferase (LRAT) activity. LRAT activity exhibited the same Km (2 microM retinol) between tissues but a higher Vmax in liver as compared to that in mammary gland (47 vs 8 pmol/min/mg microsome protein, respectively). Solvent-dispersed retinol was also esterified in a fatty acyl CoA-dependent, PMSF-resistant reaction, consistent with acyl CoA:retinol acyltransferase (ARAT) activity. Retinol bound to CRBP was not a good substrate for this reaction. ARAT activity displayed a similar Vmax (300 pmol/min/mg microsome protein) between tissues but Km values of 15 and 5 microM for retinol and fatty acyl CoA in mammary gland as compared to 30 and 25 microM, respectively, in the liver. Thus, when substrate was near or below Km, retinol esterification occurred predominantly by LRAT in the liver and ARAT in the mammary gland, respectively. The concentration of CRBP in the cytosol, determined by Western blotting, was approximately 2 microM in the liver but was almost nondetectable in the mammary gland. These data suggest that retinol esterification is regulated via different mechanisms in liver and mammary gland and support a specific role for CRBP in the liver.
在大鼠肝脏和泌乳乳腺的微粒体中,研究了视黄醇酯化作用,考察其作为视黄醇底物形式的函数、对脂肪酰辅酶A的依赖性以及对苯甲基磺酰氟(PMSF)的敏感性。与细胞视黄醇结合蛋白(CRBP)结合或分散在溶剂中的视黄醇,在不依赖脂肪酰辅酶A、对PMSF敏感的反应中被酯化,这与卵磷脂:视黄醇酰基转移酶(LRAT)的活性一致。LRAT活性在不同组织间表现出相同的Km(2 μM视黄醇),但与乳腺相比,肝脏中的Vmax更高(分别为47和8 pmol/分钟/毫克微粒体蛋白)。分散在溶剂中的视黄醇也在依赖脂肪酰辅酶A、对PMSF不敏感的反应中被酯化,这与酰基辅酶A:视黄醇酰基转移酶(ARAT)的活性一致。与CRBP结合的视黄醇不是该反应的良好底物。ARAT活性在不同组织间表现出相似的Vmax(300 pmol/分钟/毫克微粒体蛋白),但乳腺中视黄醇和脂肪酰辅酶A的Km值分别为15和5 μM,而肝脏中分别为30和25 μM。因此,当底物接近或低于Km时,视黄醇酯化分别主要由肝脏中的LRAT和乳腺中的ARAT进行。通过蛋白质印迹法测定,肝脏胞质溶胶中CRBP的浓度约为2 μM,但在乳腺中几乎检测不到。这些数据表明,视黄醇酯化在肝脏和乳腺中通过不同机制进行调节,并支持CRBP在肝脏中的特定作用。